
News
STAT+: Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid
SAN FRANCISCO — For months, drugmakers have been pleading with regulators to lower the bar for authorizing antibody drugs for Covid. The virus, they noted, had evolved fast enough to… […]